vs
GRAHAM CORP（GHM）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是GRAHAM CORP的1.3倍（$75.5M vs $56.7M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 20.5%），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $2.4M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 7.5%）
格雷厄姆控股公司是一家多元化的美国控股集团，总部位于弗吉尼亚州阿灵顿县，在特拉华州注册成立，该集团曾是《华盛顿邮报》与《新闻周刊》杂志的所有者。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
GHM vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.3倍
$56.7M
营收增速更快
PBYI
高出7.2%
20.5%
自由现金流更多
PBYI
多$12.0M
$2.4M
两年增速更快
PBYI
近两年复合增速
7.5%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $56.7M | $75.5M |
| 净利润 | $2.8M | — |
| 毛利率 | 23.8% | 69.3% |
| 营业利润率 | 5.5% | 22.7% |
| 净利率 | 5.0% | — |
| 营收同比 | 20.5% | 27.7% |
| 净利润同比 | 79.2% | — |
| 每股收益（稀释后） | $0.25 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GHMPBYI
| Q4 25 | $56.7M | $75.5M | ||
| Q3 25 | $66.0M | $54.5M | ||
| Q2 25 | $55.5M | $52.4M | ||
| Q1 25 | $59.3M | $46.0M | ||
| Q4 24 | $47.0M | $59.1M | ||
| Q3 24 | $53.6M | $80.5M | ||
| Q2 24 | $50.0M | $47.1M | ||
| Q1 24 | $49.1M | $43.8M |
净利润GHMPBYI
| Q4 25 | $2.8M | — | ||
| Q3 25 | $3.1M | $8.8M | ||
| Q2 25 | $4.6M | $5.9M | ||
| Q1 25 | $4.4M | $3.0M | ||
| Q4 24 | $1.6M | — | ||
| Q3 24 | $3.3M | $20.3M | ||
| Q2 24 | $3.0M | $-4.5M | ||
| Q1 24 | $1.3M | $-4.8M |
毛利率GHMPBYI
| Q4 25 | 23.8% | 69.3% | ||
| Q3 25 | 21.7% | 77.7% | ||
| Q2 25 | 26.5% | 76.5% | ||
| Q1 25 | 27.0% | 77.1% | ||
| Q4 24 | 24.8% | 76.4% | ||
| Q3 24 | 23.9% | 63.9% | ||
| Q2 24 | 24.8% | 77.4% | ||
| Q1 24 | 25.9% | 75.5% |
营业利润率GHMPBYI
| Q4 25 | 5.5% | 22.7% | ||
| Q3 25 | 6.5% | 17.6% | ||
| Q2 25 | 8.9% | 12.7% | ||
| Q1 25 | 9.3% | 8.7% | ||
| Q4 24 | 4.7% | 22.6% | ||
| Q3 24 | 7.9% | 27.4% | ||
| Q2 24 | 6.5% | -4.6% | ||
| Q1 24 | 3.1% | -5.3% |
净利率GHMPBYI
| Q4 25 | 5.0% | — | ||
| Q3 25 | 4.7% | 16.2% | ||
| Q2 25 | 8.3% | 11.2% | ||
| Q1 25 | 7.4% | 6.5% | ||
| Q4 24 | 3.4% | — | ||
| Q3 24 | 6.1% | 25.2% | ||
| Q2 24 | 5.9% | -9.6% | ||
| Q1 24 | 2.7% | -11.0% |
每股收益（稀释后）GHMPBYI
| Q4 25 | $0.25 | $0.26 | ||
| Q3 25 | $0.28 | $0.17 | ||
| Q2 25 | $0.42 | $0.12 | ||
| Q1 25 | $0.40 | $0.06 | ||
| Q4 24 | $0.14 | $0.40 | ||
| Q3 24 | $0.30 | $0.41 | ||
| Q2 24 | $0.27 | $-0.09 | ||
| Q1 24 | $0.11 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $22.3M | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $131.3M | $130.3M |
| 总资产 | $292.9M | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资GHMPBYI
| Q4 25 | $22.3M | $97.5M | ||
| Q3 25 | $20.6M | $94.4M | ||
| Q2 25 | $10.8M | $96.0M | ||
| Q1 25 | $21.6M | $93.2M | ||
| Q4 24 | $30.0M | $101.0M | ||
| Q3 24 | $32.3M | $96.7M | ||
| Q2 24 | $21.6M | $96.8M | ||
| Q1 24 | $16.9M | $107.2M |
总债务GHMPBYI
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益GHMPBYI
| Q4 25 | $131.3M | $130.3M | ||
| Q3 25 | $127.6M | $115.3M | ||
| Q2 25 | $123.4M | $104.7M | ||
| Q1 25 | $119.6M | $97.1M | ||
| Q4 24 | $114.4M | $92.1M | ||
| Q3 24 | $112.5M | $71.1M | ||
| Q2 24 | $108.2M | $48.5M | ||
| Q1 24 | $105.6M | $51.0M |
总资产GHMPBYI
| Q4 25 | $292.9M | $216.3M | ||
| Q3 25 | $287.0M | $202.9M | ||
| Q2 25 | $252.3M | $194.9M | ||
| Q1 25 | $264.1M | $196.2M | ||
| Q4 24 | $264.3M | $213.3M | ||
| Q3 24 | $249.5M | $220.7M | ||
| Q2 24 | $244.2M | $205.0M | ||
| Q1 24 | $233.9M | $214.1M |
负债/权益比GHMPBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $4.8M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $2.4M | $14.4M |
| 自由现金流率自由现金流/营收 | 4.3% | 19.1% |
| 资本支出强度资本支出/营收 | 4.1% | 0.0% |
| 现金转化率经营现金流/净利润 | 1.67× | — |
| 过去12个月自由现金流最近4个季度 | $-6.1M | $41.7M |
8季度趋势，按日历期对齐
经营现金流GHMPBYI
| Q4 25 | $4.8M | $14.4M | ||
| Q3 25 | $13.6M | $9.7M | ||
| Q2 25 | $-2.3M | $14.1M | ||
| Q1 25 | $-3.6M | $3.6M | ||
| Q4 24 | $5.2M | $15.6M | ||
| Q3 24 | $13.9M | $11.0M | ||
| Q2 24 | $8.7M | $1.0M | ||
| Q1 24 | $8.6M | $11.2M |
自由现金流GHMPBYI
| Q4 25 | $2.4M | $14.4M | ||
| Q3 25 | $9.4M | $9.7M | ||
| Q2 25 | $-9.3M | $14.1M | ||
| Q1 25 | $-8.7M | $3.6M | ||
| Q4 24 | $-2.1M | $15.6M | ||
| Q3 24 | $10.4M | $11.0M | ||
| Q2 24 | $5.7M | $1.0M | ||
| Q1 24 | $4.6M | — |
自由现金流率GHMPBYI
| Q4 25 | 4.3% | 19.1% | ||
| Q3 25 | 14.3% | 17.7% | ||
| Q2 25 | -16.7% | 26.8% | ||
| Q1 25 | -14.7% | 7.7% | ||
| Q4 24 | -4.5% | 26.4% | ||
| Q3 24 | 19.5% | 13.7% | ||
| Q2 24 | 11.5% | 2.1% | ||
| Q1 24 | 9.4% | — |
资本支出强度GHMPBYI
| Q4 25 | 4.1% | 0.0% | ||
| Q3 25 | 6.3% | 0.0% | ||
| Q2 25 | 12.6% | 0.0% | ||
| Q1 25 | 8.7% | 0.1% | ||
| Q4 24 | 15.6% | 0.0% | ||
| Q3 24 | 6.5% | 0.0% | ||
| Q2 24 | 6.0% | 0.0% | ||
| Q1 24 | 8.2% | 0.0% |
现金转化率GHMPBYI
| Q4 25 | 1.67× | — | ||
| Q3 25 | 4.40× | 1.10× | ||
| Q2 25 | -0.49× | 2.41× | ||
| Q1 25 | -0.81× | 1.21× | ||
| Q4 24 | 3.29× | — | ||
| Q3 24 | 4.25× | 0.54× | ||
| Q2 24 | 2.94× | — | ||
| Q1 24 | 6.45× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GHM
| Defense | $35.3M | 62% |
| Energy And Process | $18.3M | 32% |
| Space | $3.1M | 6% |
PBYI
暂无分部数据
